Cart is empty A new Concordia-led analysis concludes that the primary COVID-19 vaccines provided adequate protection against transmission, hospitalization and death. However, their effectiveness waned in subsequent months, and fell below acceptable levels in the face of the Omicron variant.
Experts examine the safety of probiotics
Scientific evidence assessing the benefits and risks of probiotics continues to accumulate. With new types of probiotics being introduced on the market and health care professionals recommending probiotic use in populations other than generally healthy individuals, continual attention to probiotic safety is warranted.
The potential and challenges of mucosal COVID-19 vaccines
In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.
Why did the mpox epidemic wane? Belgian researchers offer a theory
Did the recent mpox (formerly known as monkeypox) outbreak end because of “network immunity”? That’s the theory being put forward by Belgian researchers at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (April 15-18).
British woman infected with dengue in the south of France
Doctors in the UK and France give details of a British woman who was infected with dengue while visiting family near Nice in September 2022, in a case report being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April).
Two-thirds of staff, residents of long-term care facilities in England developed COVID-19 during early years of pandemic
Two-thirds of staff and residents in long-term care facilities for older people across England were infected with COVID-19 during the first two years of the pandemic, according to new findings from the Vivaldi study being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April).
Over 40% of healthy moms preparing for fecal transplant to C-section babies found to carry potentially harmful pathogens
A randomized trial assessing whether the oral transfer of gut microbiota from mother to baby can safely restore normal microbiota after cesarean section (C-section) has found that over 42% of healthy mothers tested positive for potentially harmful pathogens and were unable to proceed with the transplant.
Buprenorphine cuts risk for death after nonfatal, opioid-involved overdose
Buprenorphine treatment after nonfatal opioid-involved overdose is associated with significant decline in the risk for opioid-involved overdose death, according to a study published online March 10 in the American Journal of Preventive Medicine.
Low-profile design could aid treatment of rib flaring—and patients’ mental health
Body image can have a significant impact on a person’s life, especially in their youth.
Durability of bivalent boosters against omicron subvariants
New research led by the UNC Gillings School of Global Public Health shows that bivalent COVID-19 boosters are still providing effective protection from hospitalization and death, even against the most recent omicron subvariants.